AzTrials
AzTrials

AlcoholismCRAVING-NETNCT05275166

Study of the Neural Substrates of Alcohol Craving by High-resolution Electroencephalography

A study testing Induction of alcohol craving and Questionnaires in people with Alcoholism and Alcohol Dependence, run by Rennes University Hospital.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Alcohol is the most consumed psychoactive substance in France and is responsible for 49,000 deaths per year in the country. Addictions, characterized by "the repeated impossibility of controlling a behavior and the continuation of this behavior despite the knowledge of its negative consequences", are a major public… Read more about this study

Who is it for?
Ages 30 to 60 years, men onlyHealthy volunteers can take part
Conditions the study is for
Alcoholism, Alcohol Dependence
What is being tested?
Induction of alcohol craving and Questionnaires
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
May 2023to Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 60 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients (N=20):
  • Subject with moderate to severe DSM-5 alcohol use disorder hospitalized for withdrawal as part of their routine care.
  • Presence of spontaneous and/or in response to environmental stimuli (induced) self-described episodes of craving.
  • Males with age ≥ 30 years and ≤ 60 years;
  • Normal or corrected-to-normal visual acuity (declarative);
  • Right-handed;
Show all 12Show fewer
  • Healthy control volunteers (N=40):
  • Men with age ≥ 30 years and ≤ 60 years;
  • Normal or corrected-to-normal visual acuity;
  • Right-handed;
  • Smoker (current user, N=20) or Nonsmoker (never smoked, N=20);
  • Alcohol consumption below the low-risk drinking threshold (<10 standard drinks per week)

Who cannot join

  • For all subjects:
  • Alcohol use in the 24 hours prior to the experiment;
  • Consumption of psychoactive substances other than tobacco and alcohol (positive urine test).
  • Presence of a contraindication related to the MRI technique
  • Being under legal protection, and/or deprived of freedom;
  • Not mastering the French language (written and oral);
Show all 14Show fewer
  • Inability to understand the information given on the study and/or to carry out the experimental task.
  • For patients:
  • Presence of cognitive impairment (MoCA score < 25)
  • Absence of spontaneous or induced craving episodes
  • Decompensated cirrhosis: ascites and/or encephalopathy and/or jaundice and/or recent hemorrhage
  • For healthy control volunteers:
  • Significant medical or surgical history related to the central nervous system;
  • Current use (< 30 days) of drugs affecting the central nervous system belonging to the class of antidepressants, sleeping pills and/or anxiolytics.

About this study

Alcohol is the most consumed psychoactive substance in France and is responsible for 49,000 deaths per year in the country. Addictions, characterized by "the repeated impossibility of controlling a behavior and the continuation of this behavior despite the knowledge of its negative consequences", are a major public health issue in France and worldwide. Alcohol dependence (DSM-5 moderate to severe use disorder) is a chronic behavioral disorder, whose main characteristic is its high and prolonged risk of "relapse", i.e. the resumption of problematic consumption after a period of improvement (abstinence or reduction).

One of the main components of addiction is "craving", which can be defined as the irrepressible desire to use a substance (DSM-5, American Psychiatric Association). To date, despite functional imaging studies (fMRI), the brain mechanisms involved in craving remain poorly understood. In recent years, a new neuroimaging device has become available, both in research and in clinical settings: high-resolution electroencephalography (HRE). This non-invasive method allows to observe brain activity at the millisecond level.

The objective of the CRAVING-NET project is to better understand brain function in alcohol addiction, and in particular in craving.

Read the detailed description

The objective of the CRAVING-NET project is to better understand brain function in alcohol addiction, and in particular in craving, using high-resolution electroencephalography. Brain activity following the induction of alcohol craving, as well as responses to questionnaires related to their relationship to alcohol and their state of health, which will be obtained in patients will be compared to the same responses in healthy volunteers.

Being tested
Induction of alcohol craving, Questionnaires
Keywords
alcoholism, electroencephalography, brain activity
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Induction of alcohol cravingBehavioural

    Presentation of images that may induce craving for alcohol. Recording of brain activity

  • QuestionnairesOther

    Questionnaires related to alcohol, quality of life, anxiety and depression

Study groups in NCT05275166
Study groupRoleWhat they receive
PatientsOtherPatients hospitalized for rehab. HRE following induction of alcohol craving and questionnaires
Receives: Behavioral: Induction of alcohol craving; Other: Questionnaires
Healthy VolunteersOtherHealthy Volunteers with non alcohol dependance. HRE following induction of alcohol craving and questionnaires
Receives: Behavioral: Induction of alcohol craving; Other: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Source connectivity within large-scale brain networks

    Difference in source connectivity within large-scale brain networks following the induction of craving episodes between alcohol-dependent patients and matched healthy participants (smokers and non-smokers). Source connectivity is measured by the strength of connections between brain regions (ratio value between 0 (no communication) and 1 (strong communication)).

    Measured: 1 day

Secondary outcomes (5)
  1. Variation in source connectivity based on AUQ

    Significant difference in source connectivity between patients and volunteers based on Alcohol Urge Questionnaire (AUQ,easures craving in patients with alcohol dependence; Each item is scored on a 1 to 7 scale (Strongly Disagree = 1 and Strongly Agree = 7). Items 2 and 7 are reverse scored. A total score is computed by averaging the item scores. Higher scores reflect greater craving.

    Measured: 1 day

  2. Variation in source connectivity based on OCDS

    Significant difference in source connectivity between patients and volunteers based on Obsessive Compulsive Drinking Scale (OCDS , allows to obtain a global alcohol appetite score and to evaluate the craving, in 14 items with a compulsion sub-score and an obsessional sub-score. Higher scores reflect greater craving.

    Measured: 1 day

  3. Variation in source connectivity based on psychological state

    Significant difference in source connectivity between patients and volunteers based on Hospital Anxiety and Depression scale (HAD , allows to obtain a anxiety score and a depression score to evaluate psychological state. Two subscores, one for anxiety and one for depression. Higher sub-scores reflect higher anxiety or depression.

    Measured: 1 day

  4. Correlation between brain networks estimated by HRE and AUQ and OCDS scores

    Correlation between brain networks estimated by EEG-HR and AUQ and OCDS scores at 6 months only in patients

    Measured: 6 months

  5. Correlation between EEG-HR and fMRI networks at inclusion

    Correlation between EEG-HR and fMRI networks at inclusion in patients and healthy volunteers

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2022
  2. Study startMay 2023 (estimated)
  3. Primary completionMay 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Why it stopped: technical resources not available

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05275166
Sponsor's protocol ID
35RC21_9740_CRAVING-NET
Acronym
CRAVING-NET
Status last verified
Nov 2023
First submitted
2 Mar 2022
Last updated
4 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Induction of alcohol craving and Questionnaires in people with Alcoholism and Alcohol Dependence, run by Rennes University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 4 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Source connectivity within large-scale brain networks (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in